Bruno Murzi

Dr. Bruno Murzi


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VMVladimir Milovanovic
Vladimir Milovanovic
Dejan BisenicDejan Bisenic
Dejan Bisenic
BMBranko Mimic
Branko Mimic
BABilal Ali
Bilal Ali
Massimiliano CantinottiMassimiliano Cantinotti
Massimiliano Cantinotti
SISlobodan Ilic
Slobodan Ilic
Objective(s): Modified ultrafiltration has gained wide acceptance as a powerful tool against cardiopulmonary bypass morbidity in pediatric cardiac surgery. The aim of our study was to assess the importance of modified ultrafiltration within conditions of contemporary cardiopulmonary bypass characteristics. Methods: Ninety–eight patients (overall cohort) weighing less than 12 kg undergoing surgical repair with cardiopulmonary bypass were prospectively enrolled in a randomized protocol to receive modified and conventional ultrafiltration (MUF group) or just conventional ultrafiltration (non-MUF group). A special attention was paid to forty-nine neonates and infants weighing less than 5 kg (lower weight (LW) cohort). Results: Post-filtration hematocrit was significantly higher in the MUF group for both cohorts (overall cohort p = 0.001; LW cohort p = 0.04), but not at other time points. During the postoperative course, patients in the MUF group received fewer packed red blood cells, (overall cohort p = 0.01; LW cohort p = 0.07), but required more fresh frozen plasma (overall cohort p = 0.04; LW cohort p = 0.05). There was no difference between groups in hemodynamic state, chest tube output, duration of mechanical ventilation, respiratory parameters, duration of intensive care unit, and hospitalization stay. Conclusions: If conventional ultrafiltration provides adequate hemoconcentration modified ultrafiltration does not provide additional positive benefits except for reduction in blood cell transfusion, This, however, comes at the cost of needing more fresh frozen plasma. Of particular importance is that this also applies to infants with weight bellow 5 kg where modified ultrafiltration was supposed to have the greatest positive impact.

1 January 2013 in Circulation Journal
Verified
Journal Article
Closed access
Massimiliano CantinottiMassimiliano Cantinotti
Massimiliano Cantinotti
VLValentina Lorenzoni
Valentina Lorenzoni
SSSimona Storti
Simona Storti
RMRiccardo Moschetti
Riccardo Moschetti
BMBruno Murzi
Bruno Murzi
GIGiorgio Iervasi
Giorgio Iervasi
Interest in hormonal response after pediatric cardiac surgery is growing, but many aspects remain unclear. The aim of this study was to test age-related variations and prognostic values of thyroid hormones, and brain natriuretic peptide (BNP) levels before and after surgery. A total of 162 children undergoing cardiac surgery were divided into 3 age groups (group 1, n=57 neonates; group 2, n=58 infants; group 3, n=47 toddlers). Free thyroid hormones (fT3 and fT4), thyrotropin (thyroid-stimulating hormone [TSH]) and BNP were measured preoperatively, daily postoperatively in the intensive care unit and after 15 days. The primary outcome was time to extubation (TTE; variable used as time to event by survival analysis). The hormonal response differed among age groups. In older children the TSH nadir occurred at 6-12h after surgery (0.42 mIU/L, P<0.001), with a progressive recovery thereafter, while in neonates the TSH nadir occurred later, at 36-60 h (0.14 mIU/L, P<0.001), followed by a much slower recovery. In neonates, BNP also dropped after surgery (from 2,899 to 824.0 ng/L, P<0.001) while increased in older children (from 71.00 to 527.00 ng/L, P<0.001). On multivariate analysis independent predictors of TTE were fT3 nadir in all age groups, together with TSH nadir and Aristotle score in neonates, and body surface area and BNP peak in older children. BNP and thyroid response after pediatric cardiac surgery differs widely according to age. Beside Aristotle score, combined measurement of fT3 and TSH are the strongest predictors of TTE, especially in neonates.

24 November 2015 in The Thoracic and Cardiovascular Surgeon
Verified
Journal Article
Closed access
PDF file
LALuigi Arcieri
Luigi Arcieri
Massimiliano CantinottiMassimiliano Cantinotti
Massimiliano Cantinotti
VPVitali Pak
Vitali Pak
VPVincenzo Poli
Vincenzo Poli
AMAnna Maizza
Anna Maizza
Raffaele GiordanoRaffaele Giordano
Raffaele Giordano
Background The cardioplegia is one of the most significant tools used to increase myocardial protection. The aim of our study is to compare the use of Custodiol solution versus intermitted blood cardioplegia in a retrospective analysis of data for patients who underwent arterial switch operation in our institution. Material and Methods From January 2008 to March 2011, myocardial protection was performed in 44 neonates (blood group) with intermittent blood cardioplegia. From March 2011 to November 2014, myocardial protection was performed in 50 neonates (Custodiol group) with one-shot anterograde Custodiol cardioplegia. Results Cardiopulmonary bypass and aortic cross-clamp were more favorable in Custodiol group (p-value 0.005 and ≤ 0.00001). The rate of delayed sternal closure was 63.6% in the blood group and 52% in the Custodiol group (p = 0.25). In the postoperative outcomes we did not find differences between the two groups. The 30-day mortality was one patient in the blood group (p = 0.46). We observed a transient ischemic electrocardiogram in 10 patients of the blood group and in 14 of the Custodiol group (p = 0.72), all cases with full resolution during hospitalization without coronary reoperation. A trend of higher peak of troponin-I and brain natriuretic peptide in Custodiol group has been reported. Conclusion No prefect cardioplegia exists, the Custodiol solution does not cause extra/additional myocardial damage in arterial switch operation. In our experience this strategy seems warranted to simplify the procedure and to be more comfortable for the surgeon.

29 December 2014 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
Raffaele GiordanoRaffaele Giordano
Raffaele Giordano
Massimiliano CantinottiMassimiliano Cantinotti
Massimiliano Cantinotti
VPVitali Pak
Vitali Pak
LALuigi Arcieri
Luigi Arcieri
VPVincenzo Poli
Vincenzo Poli
BMBruno Murzi
Bruno Murzi
Mitral valve replacement (MVR) is a surgical option when mitral valvuloplasty is not feasible/successful. This study reviews our experience with MVR in very young children. From July 2004 to January 2014, seven children (mean age 13.3 ± 11.2 months; range 4 months to 35 months; mean body weight 6.0 ± 2.2 kg) underwent MVR with a mechanical prosthesis in the supra-annular position. To provide better exposure in the left atrium, we performed in all but one case a biatrial transeptal incision according to Guiraudon. Six patients had congenital defects of the mitral valve and one had rheumatic. Six patients had undergone previous cardiosurgical procedures. All patients were implanted with a CarboMedics (CarboMedics, Austin, TX, USA) mechanical prosthesis. Mean prosthesis size was 19.0 ± 3.1 mm (range 16 to 25). There were no cases of operative or late mortality. At follow-up (mean 67.1 ± 34.8 months; range 25 to 108 months) two patients (28.6%) required reoperation both for thrombotic pannus formation over the disc at two and three months from first operation, respectively; only in one case was replacement necessary. Supra-annular MVR may be considered a feasible secondary surgical option in children with a small annulus when mitral valvuloplasty is unsuccessful or unsuitable. Early and mid-term outcomes are acceptable but complications are not uncommon, especially related to thrombotic events.

1 January 2010 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
RMRafik Margaryan
Rafik Margaryan
LALuigi Arcieri
Luigi Arcieri
Massimiliano CantinottiMassimiliano Cantinotti
Massimiliano Cantinotti
BMBruno Murzi
Bruno Murzi
Big pulmonary artery-left atrial fistula malformation (PALAF) was diagnosed in a 5-year-old boy. Although transcatheter therapy would be preferred as a treatment of PALAF, the lesion, which was 20 mm in diameter and almost totally shunting the right main pulmonary artery, it was decided to treat by surgical approach.

11 February 2014 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
LALuigi Arcieri
Luigi Arcieri
Massimiliano CantinottiMassimiliano Cantinotti
Massimiliano Cantinotti
VPVitali Pak
Vitali Pak
MBMassimo Bernabei
Massimo Bernabei
NANadia Assanta
Nadia Assanta
BMBruno Murzi
Bruno Murzi
Preoperative aortopulmonary mismatch is considered a risk factor for the development of aortic insufficiency after surgery for transposition of the great arteries. We have approached these children using a neoaortic root reduction plasty. Five children with severe PA-AO discrepancy (median age 57 days) underwent arterial switch operation (ASO) associated with a V-shape neoaortic reduction plasty. At follow-up aortic regurgitation remains stable in all patients and no supra-aortic obstruction and/or neoaortic root dilatation were observed.